• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小胶质细胞在视神经脊髓炎谱系疾病中的作用和机制。

The role and mechanisms of Microglia in Neuromyelitis Optica Spectrum Disorders.

机构信息

Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.

Institute of Clinical Pharmacy, Central South University, Changsha, 410011, Hunan, China.

出版信息

Int J Med Sci. 2021 Jun 16;18(14):3059-3065. doi: 10.7150/ijms.61153. eCollection 2021.

DOI:10.7150/ijms.61153
PMID:34400876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8364446/
Abstract

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune neurological disease that can cause blindness and disability. As the major mediators in the central nervous system, microglia plays key roles in immunological regulation in neuroinflammatory diseases, including NMOSD. Microglia can be activated by interleukin (IL)-6 and type I interferons (IFN-Is) during NMOSD, leading to signal transducer and activator of transcription (STAT) activation. Moreover, complement C3a secreted from activated astrocytes may induce the secretion of complement C1q, inflammatory cytokines and progranulin (PGRN) by microglia, facilitating injury to microglia, neurons, astrocytes and oligodendrocytes in an autocrine or paracrine manner. These processes involving activated microglia ultimately promote the pathological course of NMOSD. In this review, recent research progress on the roles of microglia in NMOSD pathogenesis is summarized, and the mechanisms of microglial activation and microglial-mediated inflammation, and the potential research prospects associated with microglial activation are also discussed.

摘要

视神经脊髓炎谱系疾病(NMOSD)是一种自身免疫性神经系统疾病,可导致失明和残疾。小胶质细胞作为中枢神经系统的主要介质,在包括 NMOSD 在内的神经炎症性疾病的免疫调节中发挥关键作用。在 NMOSD 期间,小胶质细胞可被白细胞介素(IL)-6 和 I 型干扰素(IFN-Is)激活,导致信号转导和转录激活因子(STAT)激活。此外,活化星形胶质细胞分泌的补体 C3a 可能诱导小胶质细胞分泌补体 C1q、炎性细胞因子和颗粒蛋白(PGRN),以自分泌或旁分泌方式促进小胶质细胞、神经元、星形胶质细胞和少突胶质细胞损伤。这些涉及活化小胶质细胞的过程最终促进 NMOSD 的病理过程。本文总结了小胶质细胞在 NMOSD 发病机制中的作用的最新研究进展,并讨论了小胶质细胞活化的机制以及小胶质细胞介导的炎症,以及与小胶质细胞活化相关的潜在研究前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eba5/8364446/863d96def513/ijmsv18p3059g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eba5/8364446/991fae91c32f/ijmsv18p3059g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eba5/8364446/863d96def513/ijmsv18p3059g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eba5/8364446/991fae91c32f/ijmsv18p3059g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eba5/8364446/863d96def513/ijmsv18p3059g002.jpg

相似文献

1
The role and mechanisms of Microglia in Neuromyelitis Optica Spectrum Disorders.小胶质细胞在视神经脊髓炎谱系疾病中的作用和机制。
Int J Med Sci. 2021 Jun 16;18(14):3059-3065. doi: 10.7150/ijms.61153. eCollection 2021.
2
Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion.星形胶质细胞-小胶质细胞相互作用驱动视神经脊髓炎病变的进展。
J Clin Invest. 2020 Aug 3;130(8):4025-4038. doi: 10.1172/JCI134816.
3
Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders.视神经脊髓炎谱系疾病中天麻素病和补体激活的分期。
Brain. 2021 Sep 4;144(8):2401-2415. doi: 10.1093/brain/awab102.
4
TREM2 deficiency inhibits microglial activation and aggravates demyelinating injury in neuromyelitis optica spectrum disorder.TREM2 缺乏抑制小胶质细胞活化并加重视神经脊髓炎谱系疾病的脱髓鞘损伤。
J Neuroinflammation. 2023 Apr 3;20(1):89. doi: 10.1186/s12974-023-02772-3.
5
Group 2 innate lymphoid cells suppress the pathology of neuromyelitis optica spectrum disorder.2 型固有淋巴细胞抑制视神经脊髓炎谱系疾病的病理学。
FASEB J. 2021 Nov;35(11):e21856. doi: 10.1096/fj.202100673R.
6
Distinct microglial and macrophage distribution patterns in the concentric and lamellar lesions in Baló's disease and neuromyelitis optica spectrum disorders.同心圆层状和神经脱髓鞘疾病中不同的小胶质细胞和巨噬细胞分布模式。
Brain Pathol. 2020 Nov;30(6):1144-1157. doi: 10.1111/bpa.12898. Epub 2020 Sep 23.
7
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.少突胶质细胞通过星形胶质细胞损伤被视神经脊髓炎免疫球蛋白 G 损伤。
Brain. 2010 Sep;133(9):2578-91. doi: 10.1093/brain/awq177. Epub 2010 Aug 5.
8
Complement activation in patients with neuromyelitis optica.视神经脊髓炎患者的补体激活。
J Neuroimmunol. 2014 Sep 15;274(1-2):185-91. doi: 10.1016/j.jneuroim.2014.07.001. Epub 2014 Jul 11.
9
Research and progress on biomarkers of neuromyelitis optica spectrum disorders.视神经脊髓炎谱系疾病生物标志物的研究进展。
J Recept Signal Transduct Res. 2021 Oct;41(5):417-424. doi: 10.1080/10799893.2020.1830109. Epub 2020 Oct 6.
10
Serum LDL Promotes Microglial Activation and Exacerbates Demyelinating Injury in Neuromyelitis Optica Spectrum Disorder.血清 LDL 促进小胶质细胞活化并加重视神经脊髓炎谱系疾病的脱髓鞘损伤。
Neurosci Bull. 2024 Aug;40(8):1104-1114. doi: 10.1007/s12264-023-01166-y. Epub 2024 Jan 16.

引用本文的文献

1
Temporal Dynamics of APOE and TREM2 Expression in Microglial Activation of NMOSD Mouse Models.视神经脊髓炎谱系障碍(NMOSD)小鼠模型小胶质细胞激活中APOE和TREM2表达的时间动态变化
Mol Neurobiol. 2025 Jun 23. doi: 10.1007/s12035-025-05160-5.
2
4-Octyl itaconate inhibits inflammation via the NLRP3 pathway in neuromyelitis optica spectrum disorders.4-辛烯酸抑制视神经脊髓炎谱系疾病中 NLRP3 通路的炎症反应。
Ann Clin Transl Neurol. 2024 Jul;11(7):1732-1749. doi: 10.1002/acn3.52080. Epub 2024 May 13.
3
Exploring Myelin Dynamics in Demyelinating Disorders at the Molecular Level.

本文引用的文献

1
The Emerging Role of Microglia in Neuromyelitis Optica.小胶质细胞在视神经脊髓炎中的新作用。
Front Immunol. 2021 Feb 19;12:616301. doi: 10.3389/fimmu.2021.616301. eCollection 2021.
2
miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology.小胶质细胞中的 microRNAs:多发性硬化症病理中的重要参与者。
ASN Neuro. 2021 Jan-Dec;13:1759091420981182. doi: 10.1177/1759091420981182.
3
New progress in the treatment of neuromyelitis optica spectrum disorder with monoclonal antibodies (Review).单克隆抗体治疗视神经脊髓炎谱系障碍的新进展(综述)
在分子水平上探索脱髓鞘疾病中的髓鞘动态变化。
Curr Issues Mol Biol. 2024 Feb 26;46(3):1754-1756. doi: 10.3390/cimb46030114.
4
Serum LDL Promotes Microglial Activation and Exacerbates Demyelinating Injury in Neuromyelitis Optica Spectrum Disorder.血清 LDL 促进小胶质细胞活化并加重视神经脊髓炎谱系疾病的脱髓鞘损伤。
Neurosci Bull. 2024 Aug;40(8):1104-1114. doi: 10.1007/s12264-023-01166-y. Epub 2024 Jan 16.
5
Autoimmune-mediated astrocytopathy.自身免疫介导的星形细胞病
Inflamm Regen. 2023 Jul 18;43(1):39. doi: 10.1186/s41232-023-00291-5.
6
The JAK-STAT Signaling Pathway in Epilepsy.癫痫中的 JAK-STAT 信号通路。
Curr Neuropharmacol. 2023;21(10):2049-2069. doi: 10.2174/1570159X21666221214170234.
7
Correlation of IgH-CDR3 Immune Repertoire Diversity Test in Peripheral Blood of Neuromyelitis Spectrum Diseases.免疫球蛋白重链互补决定区 3 免疫受体多样性检测在神经脊髓炎谱系疾病外周血中的相关性。
Biomed Res Int. 2022 Oct 10;2022:6790145. doi: 10.1155/2022/6790145. eCollection 2022.
8
Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives.视神经脊髓炎谱系疾病:从基础研究到临床视角。
Int J Mol Sci. 2022 Jul 18;23(14):7908. doi: 10.3390/ijms23147908.
Exp Ther Med. 2021 Feb;21(2):148. doi: 10.3892/etm.2020.9579. Epub 2020 Dec 16.
4
Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2.靶向 B 细胞治疗多发性硬化症、视神经脊髓炎和 MO-GAD:第 2 部分。
Neurol Neuroimmunol Neuroinflamm. 2020 Dec 16;8(1). doi: 10.1212/NXI.0000000000000919. Print 2021 Jan.
5
Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1.靶向 B 细胞以修饰多发性硬化症、NMOSD 和 MOGA:第 1 部分。
Neurol Neuroimmunol Neuroinflamm. 2020 Dec 16;8(1). doi: 10.1212/NXI.0000000000000918. Print 2021 Jan.
6
Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.视神经脊髓炎谱系疾病和髓鞘少突胶质细胞糖蛋白相关疾病-视神经炎:诊断和治疗的综合综述。
Eye (Lond). 2021 Mar;35(3):753-768. doi: 10.1038/s41433-020-01334-8. Epub 2020 Dec 15.
7
Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review.全球视神经脊髓炎的发病率和患病率:一项系统评价。
Neurology. 2021 Jan 12;96(2):59-77. doi: 10.1212/WNL.0000000000011153. Epub 2020 Dec 11.
8
Could Galectin-3 be a key player in the etiology of neuromyelitis optica spectrum disorder?半乳糖凝集素-3会是视神经脊髓炎谱系障碍病因中的关键因素吗?
Med Hypotheses. 2021 Jan;146:110450. doi: 10.1016/j.mehy.2020.110450. Epub 2020 Dec 5.
9
Microglial replacement therapy: a potential therapeutic strategy for incurable CSF1R-related leukoencephalopathy.小胶质细胞替代疗法:一种治疗不可治愈的 CSF1R 相关脑白质营养不良的潜在治疗策略。
Acta Neuropathol Commun. 2020 Dec 7;8(1):217. doi: 10.1186/s40478-020-01093-3.
10
Type I interferon-activated microglia are critical for neuromyelitis optica pathology.I 型干扰素激活的小胶质细胞对视神经脊髓炎病理至关重要。
Glia. 2021 Apr;69(4):943-953. doi: 10.1002/glia.23938. Epub 2020 Nov 26.